DE | EN

Dr. med. Dr. rer. nat. Klaus Wethmar

Current affiliations

Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)

Publications

Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report Krekeler, C; Wethmar, K; Mikesch, JH; Kerkhoff, A; Menck, K; Lenz, G; Schildhaus, HU; Wessolly, M; Hoffmann, MW; Pascher, A; Asmus, I; Wardelmann, E; Bleckmann, A (2023) In: International Journal of Molecular Sciences, 24(15), 12056. doi:10.3390/ijms241512056 Research article (journal) \| Peer reviewed \| Published
Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer Lara Jürgens, Felix Manske, Elvira Hubert, Tabea Kischka, Lea Flötotto, Oliver Klaas, Victoria Shabardina, Christoph Schliemann, Wojciech Makalowski andKlaus Wethmar (2021) In: Biomedicines, 9(6), 618. doi:10.3390/biomedicines9060618 Research article (journal) \| Peer reviewed \| Published
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia Klaus Wethmar 1 , Svenja Matern 1 , Eva Eßeling 1 , Linus Angenendt 1 , Heike Pfeifer 2 , Monika Brüggemann 3 , Patrick Stelmach 1 , Simon Call 1 , Jörn C Albring 1 , Jan-Henrik Mikesch 1 , Christian Reicherts 1 , Christoph Groth 1 , Christoph Schliemann 1 , Wolfgang E Berdel 1 , Georg Lenz 1 , Matthias Stelljes 4 (2020) In: Bone Marrow Transplantation, 55(7). doi:10.1038/s41409-020-0801-0 Research article (journal) \| Peer reviewed \| Published
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis. Stelmach P, Wethmar K, Groth C, Wenge DV, Albring J, Mikesch JH, Schliemann C, Reicherts C, Berdel WE, Lenz G, Stelljes M. (2020) In: ((Bitte Journal prüfen)), 20(10), e724-e733. doi:10.1016/j.clml.2020.05.022 Research article (journal) \| Peer reviewed \| Published
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia Angenendt L, Bormann E, Pabst C, Alla V, Görlich D, Braun L, Dohlich K, Schwöppe C, Bohlander SK, Arteaga MF, Wethmar K, Hartmann W, Angenendt A, Kessler T, Mesters RM, Stelljes M, Rothenberg-Thurley M, Spiekermann K, Hébert J, Sauvageau G, Valk PJM, Löwenberg B, Serve H, Müller-Tidow C, Lenz G, Wörmann BJ, Sauerland MC, Hiddemann W, Berdel WE, Krug U, Metzeler KH, Mikesch J, Herold T, Schliemann C (2020) In: Leukemia, 33(12), 2830-2841. doi:10.1038/s41375-019-0505-xDO-10.1038/s41375-019-0505-x Research article (journal) \| Peer reviewed \| Published

Show all publications